Holen Sie sich die Stockscreener-App
15.14
2.51%
-0.41
Schlusskurs vom Vortag:
$15.55
Offen:
$15.8
24-Stunden-Volumen:
90,476
Relative Volume:
0.22
Marktkapitalisierung:
$939.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-41.43M
KGV:
-19.16
EPS:
-0.79
Netto-Cashflow:
$-39.97M
1W Leistung:
+14.50%
1M Leistung:
+5.94%
6M Leistung:
-2.07%
1J Leistung:
+68.82%
1-Tages-Spanne:
$14.71
$15.84
1-Wochen-Bereich:
$13.50
$19.00
52-Wochen-Spanne:
$7.98
$20.50
Gh Research Plc Stock (GHRS) Company Profile
Vergleichen Sie GHRS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
15.14 | 964.56M | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.00 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.42 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.64 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
812.45 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.41 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-13 | Eingeleitet | Needham | Buy |
| 2025-06-04 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-03-13 | Eingeleitet | Guggenheim | Buy |
| 2025-03-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-02-13 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-08-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-06-16 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Gh Research Plc Aktie (GHRS) Neueste Nachrichten
Assessing GH Research (GHRS) Valuation After FDA Lifts Clinical Hold On GH001 IND - Sahm
Is GH Research PLC (1KA) stock protected from inflationTrade Ideas & Low Risk Entry Point Tips - ulpravda.ru
Why analysts maintain buy rating on GH Research PLC (1KA) stock2025 Market Overview & Low Risk Profit Maximizing Plans - ulpravda.ru
Published on: 2026-01-09 02:32:55 - ulpravda.ru
How strong is GH Research PLC stock balance sheet2025 Valuation Update & Weekly High Conviction Ideas - ulpravda.ru
Quarterly Recap: What dividend safety score for GH Research PLC stock2025 Top Gainers & Weekly High Conviction Trade Ideas - ulpravda.ru
GH Research to Present Six-Month Safety and Efficacy Data on Inhaled GH001 in Depression at 2026 ACNP Meeting - TipRanks
Assessing GH Research (GHRS) Valuation After FDA Lifts Clinical Hold On GH001 Trials - Yahoo Finance UK
Stock market today: S&P 500, Nasdaq futures rise, WTI fluctuates following US strike on Venezuela—GH Research, Vertiv Holdings, Nukkleus in focus - MSN
Why Is GHRS Stock Rising Today? - Asianet Newsable
What drives GH Research PLC stock priceDividend Reinvestment Plans & Outstanding Capital Tips - earlytimes.in
Why is GHRS stock rising today? - MSN
Will GH Research PLC (1KA) stock gain from green policies2026 world cup usa national team round of 32 playmakers pressing system odds analysis tactical review - ulpravda.ru
GH Research (NASDAQ:GHRS) Stock Price Down 9.2%Should You Sell? - MarketBeat
GH Research stock price target raised to $29 from $19 at Needham - Investing.com Nigeria
GH Research stock rises as FDA lifts clinical hold on GH001 - Investing.com Australia
GH Research stock jumps as Canaccord raises price target on FDA hold lift - Investing.com
GHRS Stock Sees Significant Price Target Increase by Needham | G - GuruFocus
GH Research (GHRS) Is Up 24.2% After FDA Lifts Hold On GH001 U.S. Trial Enrollment - simplywall.st
Hold lifted, as GH Research preps for pivotal GH-001 depression trial - BioWorld MedTech
GH Research stock rating reiterated as Buy by TD Cowen - Investing.com Nigeria
GH Research says FDA lifts clinical hold on GH001 - TipRanks
GH Research stock rises as FDA lifts clinical hold on inhaled 5-MeO-DMT By Investing.com - Investing.com South Africa
Dow Jumps 800 Points; ISM Manufacturing PMI Falls In December - Benzinga
GH Research (NASDAQ:GHRS) Shares Gap UpTime to Buy? - MarketBeat
GH Research stock rises as FDA lifts clinical hold on inhaled 5-MeO-DMT - Investing.com Australia
GH Research stock rises as Stifel reiterates Buy rating after clinical hold lifted By Investing.com - Investing.com South Africa
Altimmune, GH Research, Gyre Therapeutics And Other Big Stocks Moving Higher On Monday - Benzinga
US Stocks Higher; Dow Jumps 250 Points - Benzinga
GH Research stock rises as Stifel reiterates Buy rating after clinical hold lifted - Investing.com Nigeria
Why Is GH Research Stock Soaring Monday?GH Research (NASDAQ:GHRS) - Benzinga
Why GH Research Is Rising In Pre-market? - Nasdaq
Stock Market Today: S&P 500, Nasdaq, WTI Crude Futures Advance After US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus (UPDATED) - Benzinga
Stock Market Today: S&P 500, Nasdaq, WTI Crude Futures Advance After US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus (UPDATED) - Benzinga
Gh Research shares jump 44% premarket after US FDA lifts clinical hold on depression drug trials - MarketScreener
GHRS: Needham Reiterates Buy Rating and $19 Price Target | GHRS Stock News - GuruFocus
GH Research surges as FDA lifts clinical hold on depression therapy - Seeking Alpha
GH Research (NASDAQ:GHRS) Receives Buy Rating from Needham & Company LLC - MarketBeat
GH Research Says FDA Lifted Clinical Hold on Investigational New Drug Application for GH001; Shares Rise Pre-Bell - marketscreener.com
GH Research Wins FDA Clearance to Advance GH001 for Treatment-Resistant Depression - TipRanks
GH Research stock soars after FDA lifts clinical hold on GH001 By Investing.com - Investing.com South Africa
GH Research stock soars after FDA lifts clinical hold on GH001 - Investing.com Australia
GH Research stock grabs retail spotlight ahead of FDA update on depression treatment - MSN
GH Research : Corporate Presentation - marketscreener.com
NextEra Energy, GH Research And 3 Stocks To Watch Heading Into Monday - Benzinga
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026 - The Manila Times
FDA clears next-step testing of fast-acting drug for tough-to-treat depression - Stock Titan
Stock Market Today: S&P 500, Nasdaq Futures Rise, WTI Fluctuates Following US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus - Benzinga
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Benzinga
GH Research Holdings Inc (NASDAQ:GHRS) Nasdaq Composite ETF Biotech Scope - Kalkine Media
What analysts say about GH Research PLC 1KA stockEnergy Sector Updates & Free Explosive Return Secrets - earlytimes.in
Finanzdaten der Gh Research Plc-Aktie (GHRS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):